Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Spodoptera littoralis | Ecdysone receptor | Starlite/ChEMBL | References |
Bombyx mori | Ecdysone receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | ecdysteroid receptor | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Onchocerca volvulus | Bile acid receptor homolog | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | ecdysone induced protein 78C | Ecdysone receptor | 585 aa | 476 aa | 25.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0419 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0395 | 0.9389 | 0.9389 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0419 | 1 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0419 | 1 | 0.5 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0419 | 1 | 1 |
Brugia malayi | ecdysteroid receptor | 0.0395 | 0.9389 | 0.9389 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0419 | 1 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0419 | 1 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0419 | 1 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0419 | 1 | 0.5 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0419 | 1 | 1 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0419 | 1 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0419 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0419 | 1 | 1 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0419 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0419 | 1 | 1 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0419 | 1 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0419 | 1 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0419 | 1 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0419 | 1 | 1 |
Leishmania major | UDP-galactopyranose mutase | 0.0419 | 1 | 0.5 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0419 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0419 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0419 | 1 | 1 |
Mycobacterium ulcerans | dehydrogenase | 0.0419 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0419 | 1 | 1 |
Onchocerca volvulus | 0.0419 | 1 | 1 | |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0419 | 1 | 0.5 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0419 | 1 | 1 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0419 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0419 | 1 | 1 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0419 | 1 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0395 | 0.9389 | 0.9389 |
Mycobacterium ulcerans | monoamine oxidase | 0.0419 | 1 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0419 | 1 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0419 | 1 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0419 | 1 | 0.5 |
Echinococcus multilocularis | 0.0419 | 1 | 1 | |
Plasmodium vivax | hypothetical protein, conserved | 0.0419 | 1 | 0.5 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0419 | 1 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0419 | 1 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0419 | 1 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0419 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 4.47 | Agonist activity at ecdysone receptor in Drosophila melanogaster S2 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20672340 |
EC50 (binding) | = 6.54 | Agonist activity at ecdysone receptor in Spodoptera littoralis Sl2 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20069627 |
EC50 (binding) | = 6.84 | Agonist activity at ecdysone receptor in Bombyx mori Bm5 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20069627 |
EC50 (binding) | = 7.29 | Agonist activity at ecdysone receptor in Bombyx mori Bm5 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20672340 |
Efficacy (binding) | = 73 % | Agonist activity at ecdysone receptor in Drosophila melanogaster S2 cells at 100 uM after 24 hr by luciferase reporter gene assay relative to 20-hydroxyecdysone | ChEMBL. | 20672340 |
Efficacy (binding) | = 93 % | Agonist activity at ecdysone receptor in Bombyx mori Bm5 cells after 24 hr by luciferase reporter gene assay relative to tebufenozide | ChEMBL. | 20069627 |
Efficacy (binding) | = 105 % | Agonist activity at ecdysone receptor in Spodoptera littoralis Sl2 cells after 24 hr by luciferase reporter gene assay relative to tebufenozide | ChEMBL. | 20069627 |
Inhibition (binding) | = 5.9 % | Inhibition of human P-glycoprotein transfected in pig LLC-GA5-COL150 cells assessed as quinidine transport from apical to basolateral side at 30 uM preincubated for 30 mins followed by quinidine addition to apical side measured after 60 mins | ChEMBL. | 27262425 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.